INTRODUCTION

 

Postural orthostatic tachycardia syndrome (POTS) is a chronic, autonomic disorder characterized by a dramatic heart rate increase upon standing, accompanied by orthostatic intolerance. Although this condition is relatively rare, affecting less than 1-2% of the developed population, effective therapies are limited, and available treatments provide modest relief to patients (1). The etiology of POTS has not been well documented in the literature, however, many factors may precipitate its onset such as trauma, pregnancy and viral infection. The debilitating nature of the symptoms handicaps patients, impairing their functional activities and drastically decreasing their quality of life (2). In the wake of the COVID-19 pandemic, survivors of COVID-19 may have a higher likelihood of developing POTS, highlighting the virus’s potential role in triggering long-term autonomic dysfunction (3). This case report highlights a unique presentation of post-COVID-19 POTS in a patient with recurrent COVID-19 infections and explores the promising therapeutic potential of stellate ganglion blocks (SGB) in managing the debilitating symptoms of this complex condition.